J2791 Rhophylac injection
Also known as: rhophylac, rho(d) immune globulin human
Injection of Rhophylac (Rho(D) immune globulin human), used for prevention of Rho(D) alloimmunization in non-sensitized Rho(D)-negative individuals.
In Plain Language
Rh prevention
Clinical Context
Used as alternative Rho(D) prophylaxis for Rho(D)-negative, non-sensitized pregnant women and post-delivery/transfusion recipients.
RVU Information
CPT J2791 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2791?
CPT J2791 (Rhophylac injection) is a J Codes (Drugs) code. Injection of Rhophylac (Rho(D) immune globulin human), used for prevention of Rho(D) alloimmunization in non-sensitized Rho(D)-negative individuals.
How is J2791 administered?
CPT J2791 is administered by a healthcare provider, typically via injection or infusion. Used as alternative Rho(D) prophylaxis for Rho(D)-negative, non-sensitized pregnant women and post-delivery/transfusion recipients. It is used by Obstetrics, Hematology.
When is CPT J2791 used?
Used as alternative Rho(D) prophylaxis for Rho(D)-negative, non-sensitized pregnant women and post-delivery/transfusion recipients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.